Literature DB >> 8491238

Plasma concentration-effect relationship of metoprolol during and after pregnancy.

S Högstedt1, A Rane.   

Abstract

The plasma drug concentration-effect relationship after an oral dose of 100 mg metoprolol has been studied in 8 women in the third trimester of a pregnancy complicated by hypertension. The study was repeated 3-5 months after parturition when all but 2 women were normotensive. Systolic and diastolic blood pressures (SBP and DBP) were measured in the sitting position followed by the change in heart rate on exercise. The average peak plasma concentration of metoprolol was almost 4-times higher in the non-pregnant state. Despite this difference, the reduction in exercise tachycardia and resting SBP was only slightly more pronounced after delivery than during pregnancy. In relation to the plasma drug concentration, metoprolol had four-times and twice the effect on heart rate and SBP during pregnancy as compared to the post partum period. The altered chronotropic response to metoprolol during pregnancy may be due to increased sensitivity or altered function of the beta-adrenergic system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8491238     DOI: 10.1007/BF00271365

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.

Authors:  G Johnsson; C G Regårdh; L Sölvell
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  Quantitative determination of metoprolol in plasma and urine by gas chromatography.

Authors:  M Ervik
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

4.  Comparison of different clearance estimates for metoprolol in the rhesus monkey.

Authors:  A Rane; S Högstedt; B Lindberg; C G Regårdh; H Jorulf
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

5.  Pregnancy-induced increase in metoprolol metabolism.

Authors:  S Högstedt; B Lindberg; D R Peng; C G Regårdh; A Rane
Journal:  Clin Pharmacol Ther       Date:  1985-06       Impact factor: 6.875

6.  Pharmacokinetics of sotalol during pregnancy.

Authors:  M F O'Hare; W Leahey; G A Murnaghan; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  The rhesus monkey as a model for studies of pregnancy induced changes in metoprolol metabolism.

Authors:  S Högstedt; B S Lindberg; C G Regårdh; U Moström; A Rane
Journal:  Pharmacol Toxicol       Date:  1990-01

8.  Pharmacokinetics of terbutaline during pregnancy.

Authors:  S Lyrenäs; A Grahnén; B Lindberg; B Lindström; G Lönnerholm
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.

Authors:  E D Gallery; D M Saunders; S N Hunyor; A Z Györy
Journal:  Br Med J       Date:  1979-06-16

10.  Plasma anticonvulsant concentrations during pregnancy.

Authors:  C M Lander; V E Edwards; M J Eadie; J H Tyrer
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  8 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 2.  Pharmacological management of hypertension in pregnancy.

Authors:  Thomas R Easterling
Journal:  Semin Perinatol       Date:  2014-10-11       Impact factor: 3.300

3.  Pharmacokinetics of metoprolol during pregnancy and lactation.

Authors:  Rachel J Ryu; Sara Eyal; Thomas R Easterling; Steve N Caritis; Raman Venkataraman; Gary Hankins; Erik Rytting; Kenneth Thummel; Edward J Kelly; Linda Risler; Brian Phillips; Matthew T Honaker; Danny D Shen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2015-12-04       Impact factor: 3.126

Review 4.  The management of pregnancy in hypertensive patients.

Authors:  R D Tunbridge
Journal:  Postgrad Med J       Date:  1994-11       Impact factor: 2.401

5.  Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?

Authors:  David M Haas; Mary DʼAlton
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

Review 6.  Pharmacogenomics in pregnancy.

Authors:  Hannah K Betcher; Alfred L George
Journal:  Semin Perinatol       Date:  2020-01-25       Impact factor: 3.300

7.  Clinical therapeutics in pregnancy.

Authors:  Maisa N Feghali; Donald R Mattison
Journal:  J Biomed Biotechnol       Date:  2011-07-06

Review 8.  Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.

Authors:  Gali Pariente; Tom Leibson; Alexandra Carls; Thomasin Adams-Webber; Shinya Ito; Gideon Koren
Journal:  PLoS Med       Date:  2016-11-01       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.